Researchers have found that a class of commonly-used heart drugs may also improve patients' responses to anti-cancer immunotherapies called PD(L)1 inhibitors, according to preliminary findings to be presented at the 32th ...
Oct 22, 2020
A team of researchers in the US and Australia have developed a way of testing potential drugs for children's cancers so as to take account of the wide genetic diversity of these diseases.
Oct 22, 2020
In the largest study of its kind, researchers have found two common genetic variants that can be used to predict whether or not cancer patients might suffer severe adverse side-effects from the drug bevacizumab.
Oct 22, 2020
